Table 3. Multivariate cox proportional hazard analysis of prognostic variables in lung cancer patients.
| For Overall Survival | For Disease-Free Survival | |||||
|---|---|---|---|---|---|---|
| Variable | HR | 95% CI | Pa | HR | 95% CI | Pa |
| Age > 59b (vs. ≤ 59 y) | 1.283 | 0.834 to 1.975 | 0.257 | 1.120 | 0.738 to 1.699 | 0.594 |
| Gender Female (vs. Male) | 0.657 | 0.400 to 1.077 | 0.096 | 0.792 | 0.494 to 1.272 | 0.336 |
| Clinical stage IV + III (vs. II + I) | 2.813 | 1.811 to 4.369 | < 0.001 | 2.564 | 1.672 to 3.932 | < 0.001 |
| P53 Positive (vs. Negative) | 1.011 | 0.643 to 1.590 | 0.961 | 1.288 | 0.830 to 1.998 | 0.259 |
| Ki67 Positive (vs. Negative) | 2.157 | 1.379 to 3.374 | 0.001 | 1.661 | 1.085 to 2.542 | 0.020 |
| Bora High expression(vs. Low expression) | 1.838 | 1.919 to 2.836 | 0.006 | 1.671 | 1.088 to 2.565 | 0.019 |
alog-rank test, bmedian age; HR, hazard ratio; CI, confidence interval.